Lv5
1230 积分 2025-12-02 加入
肺癌免疫检查点抑制剂联合放疗中国专家共识（2025版）
21天前
已完结
III期不可切除驱动基因阳性非小细胞肺癌诊疗专家共识
22天前
已完结
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small cell lung cancer: 7-year update from the phase 3 CROWN study
1个月前
已关闭
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
1个月前
已完结
Progression and expansion of ALK inhibitors against NSCLC: A dual target approach
1个月前
已完结
The past, present, and future of ALK-targeted drug discovery. European journal of medicinal chemistry, 299, 118053. Advance online publication
1个月前
已完结
Mid-term Combination Immunotherapy and its Effect on the Albumin–Bilirubin Score in Unresectable Hepatocellular Carcinoma
2个月前
已完结
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
2个月前
已完结
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
2个月前
已完结
Predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma: nomograms based on deep learning analysis of gadoxetic acid-enhanced MRI
2个月前
已完结
Superior energy storage performance via engineering crossover region with competing orders in high-entropy multilayer capacitors
2个月前
已采纳
Plastic pollution: three numbers that support a crackdown
2个月前
已采纳
GLP-1 receptor agonist fails to halt Alzheimer’s disease
2个月前
已采纳
FDA approves GLP-1 pill for obesity
2个月前
已采纳
FDA approves GLP-1 pill for obesity
2个月前
已采纳
Revealed: how the brain turns stress into a bad night's sleep
2个月前
已采纳
Monkeypox: how universities are preventing outbreaks on campus
2个月前
已采纳
What would an AI university look like and how might it change education?
2个月前
已采纳
‘We need to dismantle the stigma of alcohol dependence in academia’
2个月前
已采纳
Chats with sycophantic AI make you less kind to others
2个月前
已采纳
皖公网安备34019202002308
